Sale!

ST6GAL2 Gene Beta-Galactosamide alpha-26-Sialyltransferase 2 deficiency Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ST6GAL2 gene plays a crucial role in the biosynthesis of the sialylated glycoproteins, which are important for various biological functions, including cell signaling and immune response. The Beta-Galactosamide alpha-2,6-Sialyltransferase 2, encoded by the ST6GAL2 gene, is an enzyme that adds sialic acid to the terminal positions of glycoproteins and glycolipids. Deficiency or dysfunction in this enzyme due to genetic variations can lead to a range of physiological and developmental issues.

To diagnose conditions related to the ST6GAL2 gene deficiency, a specific genetic test is available. This test involves analyzing the DNA to identify mutations in the ST6GAL2 gene that could lead to enzyme deficiency. It’s a critical tool for healthcare providers to diagnose potential genetic disorders related to this enzyme’s malfunction, enabling them to devise appropriate treatment and management plans for affected individuals.

The genetic test for ST6GAL2 gene Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency is offered by DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The test is priced at 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used to identify the genetic variations accurately. By opting for this test at DNA Labs UAE, patients and healthcare providers can expect reliable results that can significantly aid in the understanding and management of conditions associated with ST6GAL2 gene deficiency.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ST6GAL2 Gene Beta-Galactosamide alpha-26-Sialyltransferase 2 deficiency Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Metabolic Disorders

Doctor

General Physician

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for ST6GAL2 Gene Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency

Test Details

The ST6GAL2 gene encodes for the enzyme beta-galactosamide alpha-2,6-sialyltransferase 2. This enzyme is involved in the process of adding a sugar molecule called sialic acid to proteins or lipids on the cell surface. Sialic acid plays a role in various cellular functions, including cell-cell interactions, cell signaling, and immune responses.

Deficiency in the ST6GAL2 gene can result in a condition known as ST6GAL2 deficiency. This genetic disorder is characterized by the reduced or absent activity of the beta-galactosamide alpha-2,6-sialyltransferase 2 enzyme. As a result, there is a decrease in the amount of sialic acid on cell surfaces.

A next-generation sequencing (NGS) genetic test can be used to identify mutations or variants in the ST6GAL2 gene. This test involves sequencing the DNA of an individual to identify any changes in the genetic code that may be associated with ST6GAL2 deficiency. NGS technology allows for the simultaneous analysis of multiple genes, making it a useful tool for genetic testing.

The NGS genetic test for ST6GAL2 deficiency can help diagnose individuals with this condition and provide information about the specific genetic variants present. This information can be useful for understanding the underlying cause of the disease, predicting disease progression, and guiding treatment options. It can also be used for genetic counseling and family planning purposes.

Test Name ST6GAL2 Gene Beta-Galactosamide alpha-26-Sialyltransferase 2 deficiency Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ST6GAL2 Gene Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Beta-Galactosamide alpha-2,6-Sialyltransferase 2 deficiency
Test Details

The ST6GAL2 gene encodes for the enzyme beta-galactosamide alpha-2,6-sialyltransferase 2. This enzyme is involved in the process of adding a sugar molecule called sialic acid to proteins or lipids on the cell surface. Sialic acid plays a role in various cellular functions, including cell-cell interactions, cell signaling, and immune responses.

Deficiency in the ST6GAL2 gene can result in a condition known as ST6GAL2 deficiency. This genetic disorder is characterized by the reduced or absent activity of the beta-galactosamide alpha-2,6-sialyltransferase 2 enzyme. As a result, there is a decrease in the amount of sialic acid on cell surfaces.

A next-generation sequencing (NGS) genetic test can be used to identify mutations or variants in the ST6GAL2 gene. This test involves sequencing the DNA of an individual to identify any changes in the genetic code that may be associated with ST6GAL2 deficiency. NGS technology allows for the simultaneous analysis of multiple genes, making it a useful tool for genetic testing.

The NGS genetic test for ST6GAL2 deficiency can help diagnose individuals with this condition and provide information about the specific genetic variants present. This information can be useful for understanding the underlying cause of the disease, predicting disease progression, and guiding treatment options. It can also be used for genetic counseling and family planning purposes.